Clinical Medicine Insights: Ear, Nose and Throat 2010:3 1-4
Commentary
Published on 07 Apr 2010
DOI: 10.4137/CMENT.S3147
Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Ear, Nose and Throat
Apoptosis is an active process of programmed cell death. Fas is a cell-surface protein which is expressed on activated lymphocytes and known as CD95, TNFRSF6 or APO-1. Fas-L is ligand of Fas and known as CD95 LG or TNFSF6. Apoptosis or cell death is a result of binding of Fas-L to Fas which is expressed on the surfaces of these cells. Cancer cells escape this binding by over-expression of Fas-L or down expression of Fas. Fas and Fas-L exist in membrane bound and soluble forms. The serum level of sFas and sFas-L can be evaluated by immunostaining, immunohistochemical methods, immunofluorescence, flow cytometry and Western blotting. Head and neck squamous cell carcinoma diagnosis, staging and prognosis can be evaluated early and accurately by sFas and sFas-L expression levels detection.
PDF (425.63 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
This is the most author-friendly editing process I have experienced. The publishing process of this journal was a most pleasant and productive experience and it was fast and convenient.
Facebook Google+ Twitter
Pinterest Tumblr YouTube